Phreesia, Inc. $PHR Position Increased by Moody National Bank Trust Division

Moody National Bank Trust Division grew its holdings in shares of Phreesia, Inc. (NYSE:PHR) by 63.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 195,944 shares of the company’s stock after purchasing an additional 76,345 shares during the period. Moody National Bank Trust Division owned 0.33% of Phreesia worth $3,315,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Vanguard Group Inc. boosted its position in Phreesia by 8.3% during the 3rd quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock valued at $134,177,000 after purchasing an additional 437,462 shares during the period. New York State Common Retirement Fund lifted its stake in Phreesia by 727.1% in the third quarter. New York State Common Retirement Fund now owns 136,856 shares of the company’s stock valued at $3,219,000 after buying an additional 120,309 shares during the last quarter. Squarepoint Ops LLC grew its position in shares of Phreesia by 243.6% during the second quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock worth $2,872,000 after acquiring an additional 71,553 shares during the last quarter. Greenhouse Funds LLLP grew its position in shares of Phreesia by 16.8% during the third quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock worth $91,317,000 after acquiring an additional 557,265 shares during the last quarter. Finally, Bessemer Group Inc. increased its holdings in shares of Phreesia by 1,065.9% in the 3rd quarter. Bessemer Group Inc. now owns 554,513 shares of the company’s stock worth $13,043,000 after acquiring an additional 506,954 shares during the period. 92.10% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

PHR has been the topic of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Phreesia in a report on Wednesday, January 28th. DA Davidson lowered their price objective on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Friday, January 23rd. Royal Bank Of Canada initiated coverage on Phreesia in a research note on Friday, January 9th. They set a “moderate buy” rating and a $26.00 price target for the company. Zacks Research lowered Phreesia from a “strong-buy” rating to a “hold” rating in a report on Tuesday, January 6th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $35.00 price target on shares of Phreesia in a report on Monday, December 8th. Seventeen equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $28.94.

Insiders Place Their Bets

In other news, insider David Linetsky sold 6,038 shares of Phreesia stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total transaction of $98,781.68. Following the transaction, the insider owned 223,942 shares in the company, valued at approximately $3,663,691.12. The trade was a 2.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, General Counsel Allison C. Hoffman sold 3,995 shares of the company’s stock in a transaction on Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $65,358.20. Following the transaction, the general counsel directly owned 169,661 shares in the company, valued at $2,775,653.96. The trade was a 2.30% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 60,353 shares of company stock valued at $1,006,528 over the last quarter. 5.50% of the stock is owned by insiders.

Phreesia Stock Performance

Phreesia stock opened at $11.29 on Wednesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. The company has a market cap of $680.37 million, a P/E ratio of -112.84 and a beta of 0.67. Phreesia, Inc. has a fifty-two week low of $10.75 and a fifty-two week high of $32.76. The firm’s 50 day simple moving average is $12.91 and its 200-day simple moving average is $18.10.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.